Additionally, interleukin 10 receptor, IL10RB, was identified to be significant to patients’ severity and has been previously noted as a regulator of host susceptibility to COVID-19 severity and potential drug target [40,41]. The gene discussed is IL10RB; the disease is COVID-19.